Barner studied medicine and mathematics and earned doctorates in both subjects. “As a researcher at the helm of a globally active company, he knows exactly how important science is for the economy,” said Andreas Schlüter, Secretary General of the Stifterverband, according to a statement.
Andreas Barner (born February 10, 1953 in Freiburg im Breisgau) is a German physician and mathematician. From 2009 to 2016, he was Chairman of the Board of Directors of Boehringer Ingelheim.
Barner studied medicine at the University of Freiburg and mathematics at the Swiss Federal Institute of Technology in Zurich, completing both degrees with doctorates.
After a year as a medical intern, he moved to the pharmaceutical industry and initially held various positions in the research department of the then Ciba-Geigy AG in Basel, Switzerland.
In 1992, Barner joined Boehringer Ingelheim, Ingelheim am Rhein (Germany), where he took over the management of the Medical Division, which includes global clinical research, registration, information and biometrics, and drug safety. Since July 1, 1999, he has been a member of the Executive Board, responsible for the Pharmaceutical Research, Development, and Medical Division. In 2009, he also assumed the role of Spokesperson of the Executive Board.
On June 30, 2016, Barner stepped down as Chairman of the Executive Board and joined the Shareholders’ Committee of Boehringer Ingelheim.
Barner holds positions in several scientific and industrial associations. Since June 2013, he has been President of the Stifterverband für die Deutsche Wissenschaft (Donors’ Association for the Promotion of Sciences and Humanities in Germany).[2] Barner is also a member of the Senate of the Max Planck Society[3] and a member of the Executive Board of the German Research Foundation (DFG).
He was also Chairman of the Board of the German Association of Research-Based Pharmaceutical Companies (VFA) until 2007.[4][5] He was also a member of the Executive Board of the Federation of German Industries (BDI)[6] and the Association of the Chemical Industry (VCI).[7] In 2007, he was appointed to the German Council of Science and Humanities by the German Federal President.
Barner has been a member of the Presidium of the German Evangelical Church Congress since 2008.[9] He chaired the 35th German Evangelical Church Congress in Stuttgart in 2015 as President.[10] In November 2015, he was elected as a member of the Council of the EKD[11] and re-elected in 2021.
From 2016, Barner served as Chairman of the Board of Trustees and Managing Director of the Fazit Foundation, which, as majority shareholder, controls the Frankfurter Allgemeine Zeitung. In July 2019, he swapped roles with Karl Dietrich Seikel in the Fazit Foundation and the Supervisory Board. He is now Chairman of the Supervisory Board of the Frankfurter Allgemeine Zeitung.
Since 2017, Barner has been Chairman of the Board of the Gutenberg Foundation, which supports the Gutenberg Museum in Mainz.
https://de.wikipedia.org/wiki/Andreas_Barner
https://www.aerzteblatt.de/search/result/2e63154d-5e46-4d97-acdf-ac505a891649?q=andreas+barner